chartexchange

NKTR
Nektar Therapeutics
stockNASDAQ

Market OpenNov 19, 2026 9:35:42 AM EST
34.75USD+0.959%(+0.33)4,663
Pre-marketNov 19, 2026 8:51:30 AM EST
34.22USD-0.581%(-0.20)
33.59Bid35.26Ask1.67Spread

NKTR Financials

In Q3 FY 2026 (ended ), Nektar Therapeutics (NKTR) reported revenue of $9.39M, net income of −$55.65M, operating cash flow of −$71.93M, and assets of $1.04B (filed ).

Loading financial statements…